Shimadzu Corporation

Business Details

Manufactures, sells, and services a broad range of measuring and analytical instruments, including chromatography systems, mass spectrometry systems, optical analysis systems, testing machines, and water quality measurement systems. The segment targets diverse markets such as pharmaceuticals, food, chemicals, clinical testing, and the environment, with a global sales network spanning Japan, North America, Europe, China, and other Asian regions. The company continues to expand its recurring business (reagents, consumables, and after-sales service) and to strengthen after-sales service through its Multi-Vendor Service business (Zef Scientific, Inc.).

Recent Overview

Driven by Japan, Europe/North America, and other Asian regions, sales reached a record high level; in China, private-sector demand remained sluggish but demand for pharmaceutical applications increased.

For FY2026 (ending March 2026), sales in the Measuring Instruments Business were ¥364,908 million (up 4.9% year on year), and segment profit was ¥52,578 million (up 1.0% year on year). In the life science field within healthcare, mass spectrometry systems and liquid chromatography systems for the pharmaceutical and clinical testing markets increased. In the GX/materials field, mass spectrometry systems and gas chromatography analysis systems for the environmental analysis and chemical markets increased. In China, sales declined due to sluggish private-sector demand, but demand from the university market increased on the back of government economic stimulus measures, and LCMS/MS for pharmaceutical applications increased. In North America, Zef Scientific, Inc. continued to contribute to results. A new organization overseeing the recurring business was established, putting in place a framework to strengthen the after-sales service and reagent/consumables businesses.

Key Products

Growth Drivers

• Global expansion of R&D and quality control demand for liquid chromatography systems and mass spectrometry systems in the pharmaceutical and food markets
• Expansion of the multi-vendor service business through Zef Scientific, Inc. in North America and the accumulation of recurring revenue
• Increased demand in Europe for liquid chromatography systems for government and university markets and mass spectrometry systems for water quality testing applications
• Expanding demand in other Asian regions (India, Southeast Asia, South Korea, Taiwan) for pharmaceutical and food markets
• Strengthening of new product launches and solution proposal capabilities leveraging AI and robotics
• Establishment of a new organization overseeing the recurring business for measuring instruments to strengthen and expand the after-sales service and reagent/consumables businesses
• Development and launch of application-specific dedicated systems for PFAS regulatory compliance, new energy development, and GHG reduction
• Sustained university-market demand and pharmaceutical LCMS/MS demand in China supported by government economic stimulus measures

Risks

• Risk of declining sales due to continued sluggishness in China's private-sector market (private-sector market also declined in FY2026 ending March 2026)
• Macroeconomic slowdown and increased tariff costs due to U.S. tariff policy (a certain impact has already been factored into the earnings forecast assumptions)
• Downward pressure on operating margin from increased R&D expenses, DX investment, and core system-related costs (segment profit adjustment amount expanded from ¥-1,782 million in the prior period to ¥-3,744 million)
• Risk of yen appreciation reducing the yen-translated value of overseas sales
• Rising raw material prices and logistics costs and suppressed customer investment in certain regions due to geopolitical risks (prolonged conflict in Ukraine, escalating tensions in the Middle East)